Influence of menopausal status in homocysteine plasma levels;Influencia de la menopausia en la concentración plasmática de homocisteína

Medicina Clinica

Volumn 116, Issue 6, 2001, Pages 206-208

  Fernández Miranda, Consuelo ^a   De La Calle, María ^a   Bris, José Manuel ^a   Muelas, Mercedes ^a   Gómez, Pilar ^a   Díaz Rubio, Pilar ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cholesterol; Folic acid; Homocysteine; Postmenopausal status

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SPAIN;

ADULT; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SPAIN;

EID: 0035901162     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71772-1     Document Type: Article

References (30)

1. Miller VT. Dyslipoproteinemia in women. Endocrinol Metab Clin North Am 1990; 19: 381-398.
2. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775-1781.
3. Vila N, Deulofeu R, Chamorro A, Piera C. Concentraciones plasmáticas de homocisteína en pacientes con infarto cerebral isquémico. Med Clin (Barc) 1998; 110: 605-608.
4. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease. Results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158: 862-867.
5. Fernández-Miranda C, Aranda JL, Gómez González P, Díaz-Rubio P, Estenoz J, Gómez de la Cámara A. La hiperhomocisteinemia es frecuente en pacientes con enfermedad coronaria. Estudio de 202 enfermos. Med Clin (Barc) 1999; 113: 407-410.
6. Mansoor MA, Bergmark C, Svardal A, Lonning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995; 15: 232-240.
7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
8. Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 1999; 131: 321-330.
9. Brattstrom LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia. Metabolism 1985; 34: 1073-1077.
10. Wouters MGAJ, Moorrees MThEC, Van Der Mooren MJ, Blom HJ, Boers GHJ, Schellekens LA et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995; 25: 801-805.
11. Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JCM et al. Increased plasma homocysteine after menopause. Atherosclerosis 2000; 149: 163-168.
12. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J 1999; 20: 1234-1244
13. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79-87.
14. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its ocurrence, cofactor therapy and enzymology. Arterioscler Thromb 1993; 13: 1253-1260.
15. Moustapha A, Robinson K. Homocysteine: an emerging age-related cardiovascular risk factor. Geriatrics 1999; 54: 49-63.
16. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B, Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633-641.
17. Shipchandler MT, Moore EE. Rapid, fully automated measurement of plasma homocysteine with the Abbott IMx analyser. Clin Chem 1995; 41: 991-994.
18. Arnadottir M, Hultberg B, Nilsson-Ehle, P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996; 56: 41-46.
19. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE et al. The Hordaland Homocysteine Study. JAMA 1995; 274: 1525-1533.
20. Nygard O, Refsum H, Ueland PM, Volset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263-270.
21. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW et al. Serum total homocysteine concentrations in the Third National Health and Nutrition Examinations Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331-339.
22. Blom HJ, Boers GH, Van den Elzen JP, Van Roessel JJ, Trijbels JM, Tangerman A. Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease. Eur J Clin Invest 1988; 18: 633-638.
23. Van der Mooren MJ, Wouters MGAJ, Blom HJ, Schellekens LA, Eskes TKAB, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994; 24: 733-736.
24. Van der Mooren MJ, Demacker PNM, Blom HJ, Rijke YB, Rolland R. The effect of secuential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997; 67: 67-73.
25. Mijatovic V, Kenemans P, Jakobs C, Van Baal WM, Peters-Muller ER, Van der Mooren MJ, A randomized controlled study of the effects of 17 beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91: 432-436.
26. Berger PB, Herrmann RR, Dumesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc 2000; 75: 18-23.
27. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of fclic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340: 1449-1454.
28. Homocysteine Lowering Trialists' Collaboration Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998; 316: 894-898.
29. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407-413.
30. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999; 281: 1817-1821.